Aurobindo Pharma USA Inc. recalls Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA…
- Recall date
- November 30, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0289-2019
- FDA classification
- Class III
- Brand / firm
- Aurobindo Pharma USA Inc.
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30
Get recall alerts
Free email alert whenever Aurobindo Pharma USA Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurobindo Pharma USA Inc.